Biotech

All Articles

Sanofi fails MS study, inflicting one more blow to Denali contract

.Sanofi has actually ceased a period 2 hardship of Denali Therapeutics-partnered oditrasertib in num...

Turnstone lays off 60%, agitates C-suite to stretch out cash

.Turnstone Biologics is actually lessening its headcount by 60% and shaking up its own C-suite if yo...

Gilead quits on $15M MASH wager after reviewing preclinical information

.In a year that has actually seen a confirmation as well as a range of readouts for metabolic dysfun...

Texas biotech centers cancer cells deal, pins hopes on weight problems

.Alaunos Therapies is actually axing an agreement with Precigen, losing hope licensing rights to a p...

Capricor reveals extra information for DMD therapy after triggering BLA

.Capricor Rehabs is actually taking a triumph tour for their period 2 Duchenne muscle dystrophy (DMD...

FDA spots Kezar lupus test in grip adhering to 4 individual deaths

.The FDA has actually placed Kezar Life Sciences' lupus test on hold after the biotech warned 4 deat...

Phase 3 Scholar Rock test hits SMA target, delivering stock up 200%

.A stage 3 test of Academic Stone's spinal muscular atrophy (SMA) prospect has actually reached its ...

CAMP 4 is most current to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Therapeutics has defined think about a $67 million IPO, with inflammation-focused...

Galecto acquires leukemia medication, drops bone tissue cancer asset in pivot

.A year after the failure of an idiopathic pulmonary fibrosis candidate delivered Galecto on a searc...

Judo throws down $100M to knock senseless kidney ailment

.Taking the floor covering is actually Judo Bio, an ambitious biotech equipped with $100 million to ...